Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
PaperCitations, authors & open-access status
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,585 citations, 2017 year and bronze oa status.
2,585
Citations
2017
Year
bronze
OA Status